Structure Therapeutics Inc.
GPCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001888886
No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Structure Therapeutics Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 84 | 122 | +38 |
| Shares | 32.8M | 42.7M | +9.88M (+30.1%) |
| Value | $1.64B | $1.74B | +$96.7M (+5.9%) |
New holders (55)
Institutions that held Structure Therapeutics Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (17)
Institutions that held Structure Therapeutics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Cormorant Asset Management, LP | 1,056,373 | $53.3M |
| Point72 Asset Management, L.P. | 747,100 | $37.7M |
| Jennison Associates LLC | 420,479 | $21.2M |
| First Light Asset Management, LLC | 374,412 | $18.9M |
| Holocene Advisors, LP | 281,291 | $14.2M |
| Altium Capital Management LP | 155,000 | $7.82M |
| EAM Investors, LLC | 43,978 | $2.22M |
| SVB Financial Group | 35,353 | $1.78M |
| Prudential Financial Inc | 42,000 | $1.57M |
| Boothbay Fund Management, LLC | 27,981 | $1.41M |
| Maven Securities LTD | 22,500 | $1.13M |
| Balyasny Asset Management LLC | 13,430 | $677.1K |
| UBS Oconnor LLC | 12,218 | $616.0K |
| Allianz Asset Management GmbH | 5,500 | $277.3K |
| Acuta Capital Partners, LLC | 5,000 | $252.1K |
| Washington University | 4,274 | $215.5K |
| Toth Financial Advisory Corp | 50 | $2.52K |